When a Medicare contractor opens a hospice audit, the first document it tests is the certification of terminal illness carrying the medical director's signature, because that signature is the clinical judgment the entire claim depends on. A hospice audit tests that judgment directly, and the exposure for the physician who signed it runs personally and separately from the exposure the hospice entity carries. A medical director who treats an audit notice as someone else's problem is already behind.
This guide sits within Health Law Alliance's broader Medicare audit defense coverage, alongside Medicare Audit Defense for Small Practices, Medicare Audit Preparation Checklist for Physician Practices, and The Medicare Audit Process: Contractors, Stages, and Deadlines.
Medical Director Certification Duties
Under 42 C.F.R. § 418.22, the hospice medical director, a physician designee, or a physician member of the hospice interdisciplinary group must certify that a patient's life expectancy is six months or less if the illness runs its normal course. For the initial 90-day benefit period, the attending physician must certify as well, when the patient has one; every later recertification requires only the hospice physician's signature. The regulation requires a brief narrative, tied to that patient's own clinical findings, rather than a checkbox or standardized language covering every patient, and for the third benefit period and every one after it, the narrative must explain what a face-to-face encounter with the patient found.
The medical director's duties extend past the signature. Under 42 C.F.R. § 418.102, the medical director carries overall responsibility for the medical component of the hospice's patient care program, working with each attending physician on palliation and symptom management. A hospice audit may open through a RAC review, a federal investigator's request, or a qui tam complaint, but each channel ultimately tests whether the certification tracks the local coverage determination a Medicare contractor applies and whether the sampled findings would survive extrapolation across the full claims period under review.
The Medical Director's Personal Exposure Under the False Claims Act
Civil liability under the False Claims Act attaches to the person who causes a false claim's submission, not only to the hospice entity that bills it. Under 31 U.S.C. § 3729(b)(1), a certification is knowing if the physician had actual knowledge it was false, acted in deliberate ignorance of the truth, or acted in reckless disregard of the truth; the statute requires no proof of specific intent to defraud. One certification can carry exposure for every claim the hospice bills on that patient, because Medicare requires the hospice to submit a new monthly claim for every month the patient remains under that certification, and a contractor's recoupment demand can reach back across the patient's full enrollment.
A hospice certification is not false under the Act simply because a reviewing physician later disagrees with the clinical judgment behind it. Exposure arises from certifying a patient whose own clinical record did not support the prognosis, not from a reasonable difference of opinion among physicians reviewing the file after the fact.
A medical director's compensation structure also carries exposure under the Anti-Kickback Statute when pay rises with certification or referral volume, because that arrangement can supply a financial motive invisible in the certification itself. An audit or investigation examines the medical director's contract and payment history alongside the clinical file for this reason.
Preparing the Medical Director for an Audit Interview
Once an audit raises certification concerns, the Medicare contractor, an OIG investigator, or a relator's counsel may seek to interview the medical director directly, sometimes before the hospice's own counsel has reviewed the file. The medical director should walk through the specific patient record and the narrative language at issue with defense counsel first, rather than learn the file's contents with an investigator present. Counsel should also be clear with the physician in advance about which questions touch the hospice's privilege and which should be referred back to counsel.
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.
Why Early Legal Counsel Is Critical
It is critical that hospice medical directors promptly retain experienced healthcare defense counsel upon receiving an audit notice, an investigative request, a subpoena, or any other government inquiry that names them individually. Early legal intervention can protect the physician's rights, ensure appropriate responses to government requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators on the physician's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the medical director to risk separate from whatever the hospice itself ultimately faces.
How Health Law Alliance Can Help
Health Law Alliance defends hospice medical directors and the hospices that employ them when a Medicare audit turns into scrutiny of certification practices. Our attorneys bring former prosecutors to the defense side of these reviews. If your hospice or its medical director has received an audit notice, our hospice and home health audit defense team is available for a free, confidential consultation.





